(VIANEWS) – RYANAIR HOLD. PLC (RYA.IR), RANA GRUBER (RANA.OL), BOIRON (BOI.PA) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. RYANAIR HOLD. PLC (RYA.IR)
38.7% sales growth and 24.39% return on equity
Ryanair Holdings plc, together with its subsidiaries, provides scheduled-passenger airline services in Ireland, the United Kingdom, Italy, Spain, Germany, and other European countries. It is also involved in the provision of various ancillary services, such as non-flight scheduled and Internet-related services; in-flight sale of beverages, food, duty-free, and merchandise; and marketing of car hire and accommodation services, and travel insurance through its website and mobile app. In addition, the company offers aircraft and passenger handling, ticketing, and maintenance and repair services; and markets car parking, fast-track, airport transfers, attractions, and activities on its website and mobile app, as well as sells gift vouchers. As of June 30, 2022, it had a principal fleet of approximately 483 Boeing 737 aircrafts and 29 Airbus A320 aircrafts; and offered approximately 3,000 short-haul flights per day serving approximately 225 airports. Ryanair Holdings plc was founded in 1985 and is headquartered in Swords, Ireland.
Earnings Per Share
As for profitability, RYANAIR HOLD. PLC has a trailing twelve months EPS of €-0.58.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 24.39%.
Sales Growth
RYANAIR HOLD. PLC’s sales growth for the next quarter is 38.7%.
Yearly Top and Bottom Value
RYANAIR HOLD. PLC’s stock is valued at €14.94 at 22:20 EST, under its 52-week high of €15.75 and way higher than its 52-week low of €10.09.
Volume
Today’s last reported volume for RYANAIR HOLD. PLC is 718372 which is 64.13% below its average volume of 2003140.
More news about RYANAIR HOLD. PLC.
2. RANA GRUBER (RANA.OL)
24.5% sales growth and 68.94% return on equity
Rana Gruber ASA engages in the mining, processing, and sale of iron ore concentrate. The company excavates, processes, and sells iron oxide in the form of hematite, magnetite, and iron oxide pigments. It also produces magnetite iron oxide concentrates. The company offers its products under the Colorana brands. It exports its products worldwide. Rana Gruber ASA was founded in 1937 and is headquartered in Mo i Rana, Norway.
Earnings Per Share
As for profitability, RANA GRUBER has a trailing twelve months EPS of kr7.3.
PE Ratio
RANA GRUBER has a trailing twelve months price to earnings ratio of 8.27. Meaning, the purchaser of the share is investing kr8.27 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 68.94%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter is 573.6% and a drop 29.5% for the next.
More news about RANA GRUBER.
3. BOIRON (BOI.PA)
17.3% sales growth and 8.13% return on equity
Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary, proprietary, branded homeopathic medicines. Its branded homeopathic medicines include Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; and Sédatif PC to treat anxiety and emotional, and minor sleep disorders. The company's homeopathic medicines also comprise Coryzalia for the treatment of cold symptoms and rhinitis; Homéoptic to treat eye discomfort and irritation due to various causes for adults and children; and Homéovox for vocal disorders. In addition, it provides dietary supplement; Dermoplasmine stick, baume, and mousse to treat dry lips and skin; Mag' Nuit, a formula to fall asleep; Arnitrosium for joint pain; Castor Equi Boiron ointment for treatment of cracked skin; and Storinyl, a syrup to treat colds. Further, it offers herbal medicines, such as Canephron to increase the amount of urine and to improve urinary elimination; moisturizing baby milk; and medical devices, including a range of COVID self-tests and rapid antigenic tests. The company offers its products through distribution centers, pharmacies, pharmacy chains, wholesalers, grocery and drugstores, health food stores, and online retail. Boiron SA was founded in 1932 and is headquartered in Messimy, France.
Earnings Per Share
As for profitability, BOIRON has a trailing twelve months EPS of €1.5.
PE Ratio
BOIRON has a trailing twelve months price to earnings ratio of 26.65. Meaning, the purchaser of the share is investing €26.65 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.13%.
More news about BOIRON.
4. FRØY (FROY.OL)
14% sales growth and 10.16% return on equity
Frøy ASA provides integrated service to the aquaculture industry in Norway. The company offers wellboat services, sea freight, de-lice and treatment, mooring and laying, ring washing and cage services, net washing and mending, inspection and certification, bottom mapping and documentation, slep, diving and ROV, and control system. It owns and operates 18 wellboats, 60 aqua service vessels, 3 feed transport vessels, and 13 local offices along the Norwegian coast. The company was founded in 2019 and is headquartered in Sistranda, Norway.
Earnings Per Share
As for profitability, FRØY has a trailing twelve months EPS of kr98.71.
PE Ratio
FRØY has a trailing twelve months price to earnings ratio of 0.65. Meaning, the purchaser of the share is investing kr0.65 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.16%.
More news about FRØY.
5. WEBSTEP (WSTEP.OL)
11.6% sales growth and 11.66% return on equity
Webstep ASA, together with its subsidiaries, provides information technology (IT) consultancy services to public and private businesses in Norway and Sweden. The company offers digitalization, cloud migration and integration, Internet of Things, machine learning, IT security, robotics, and analytics. Its services include consulting, digitalization, .Net, Java, open source, full stack, front and back end, user experience, integration, mobility, cloud apps, machine learning, business intelligence, big data, data warehousing, virtual robotics, Devops, application service management, and data science services; and cloud computing, cloud services, integration, sensor technology, product and service development, Beacons, enterprise user experience, web analysis, design team, Amazon Web, Azure, prediction, AI, mobility predictive modelling, predictive modelling, hackathon, business analysis, and search engine optimization services. The company serves banking, finance and insurance, public administration, agriculture and food production, IT and telecommunication, commerce, and transportation industries. The company was founded in 2000 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, WEBSTEP has a trailing twelve months EPS of kr1.38.
PE Ratio
WEBSTEP has a trailing twelve months price to earnings ratio of 22.08. Meaning, the purchaser of the share is investing kr22.08 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.66%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 16.5%, now sitting on 860.81M for the twelve trailing months.
Moving Average
WEBSTEP’s worth is way above its 50-day moving average of kr26.69 and above its 200-day moving average of kr27.72.
Volume
Today’s last reported volume for WEBSTEP is 13079 which is 40.4% below its average volume of 21947.
More news about WEBSTEP.
6. ITERA (ITERA.OL)
11.2% sales growth and 138.07% return on equity
Itera ASA, together with its subsidiaries, designs, develops, and operates digital solutions for companies and organizations in Norway, Denmark, and Slovakia. It offers data, artificial intelligence and analytics, development and architecture, test and quality assurance solutions, as well as cloud and application services. The company delivers projects and services in the strategy and consulting, customer experience, and technology and cloud transformation areas. Itera ASA was founded in 1989 and is based in Oslo, Norway.
Earnings Per Share
As for profitability, ITERA has a trailing twelve months EPS of kr0.59.
PE Ratio
ITERA has a trailing twelve months price to earnings ratio of 21.61. Meaning, the purchaser of the share is investing kr21.61 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 138.07%.
Volume
Today’s last reported volume for ITERA is 18207 which is 31.03% below its average volume of 26400.
Yearly Top and Bottom Value
ITERA’s stock is valued at kr12.75 at 22:20 EST, way under its 52-week high of kr14.50 and way above its 52-week low of kr10.50.
Sales Growth
ITERA’s sales growth is 21% for the ongoing quarter and 11.2% for the next.
More news about ITERA.
7. ORKLA (ORK.OL)
6.6% sales growth and 12.77% return on equity
Orkla ASA engages in branded consumer goods, and industrial and financial investment businesses. The company offers branded products, including frozen pizza, ketchup, soups, sauces, bread toppings, and ready-to-eat meals through grocery channels, as well as food service, convenience stores, and petrol stations. It also provides confectionery, biscuit, and snack products; and develops bran and crispbread products, as well as energy snack meals. In addition, the company offers personal care and cleaning products; dietary supplement, sport nutrition, and weight control products; wound care products and first aid equipment; painting tools; basic and wool garments for men, women, and children; and professional cleaning products. Further, it operates Gymgrossisten, Proteinfabrikken, Bodystore, and Fitnessmarket e-commerce portals for health and sports nutrition products; and restaurants. Additionally, the company supplies margarine and butter blends, bread and cake improvers and mixes, yeast, marzipan, and ice cream ingredients; produces and supplies hydro power to the Nordic power market; and develops and sells real estate properties. It offers its food products under the Grandiosa, TORO, Stabburet, Felix, Paulúns, NATURLI', Abba, Beauvais, Den Gamle Fabrik, Spilva, and Vitana brands; confectionery and snacks under the KiMs, Nidar, Stratos, Sætre, Göteborgs Kex, OLW, Panda, Laima, Selga, Taffel, Kalev, and Nói Síríus brands; health and sports nutrition under e Zalo, Jif, Bliw, Grumme, Blenda, Define, Möller's, Collett, Nutrilett, Maxim, Norgesplaster, and Salvequick brands; and food ingredients under the Odense, Mors Hjemmebakte, KronJäst, Bakkedal, and NATURLI brands. It has operations in Norway, Sweden, Denmark, Finland, Iceland, the Baltics, rest of Europe, and internationally. The company was founded in 1918 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, ORKLA has a trailing twelve months EPS of kr4.37.
PE Ratio
ORKLA has a trailing twelve months price to earnings ratio of 17. Meaning, the purchaser of the share is investing kr17 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.77%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 14.6%, now sitting on 58.39B for the twelve trailing months.
More news about ORKLA.
